All CCR4 ligand chemokines are shown to be involved in COVID-19 associated immunity; however, it is more common for all of them, except RANTES/CCL5 and MDC/CCL22, to show elevated concentrations in blood plasma [17,18,19]. Here, CCL22 is linked to COVID-19.